Mechanism of Buyang Huanwu Decoction in protecting ischemic myocardium by regulating platelet autophagy in rats with acute myocardial infarction.
10.19540/j.cnki.cjcmm.20230510.704
- Author:
Jia-Ming GAO
1
;
Hao GUO
1
;
Ye-Hao ZHANG
1
;
Ling-Mei LI
1
;
Gao-Jie XIN
1
;
Zi-Xin LIU
1
;
Yue YOU
1
;
Yuan-Yuan CHEN
1
;
Jian-Xun LIU
1
;
Jian-Hua FU
1
Author Information
1. Beijing Key Laboratory of Pharmacology of Chinese Materia Medica, National Clinical Research Center for Chinese Medicine Cardiology, Institute of Basic Medicine, Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091, China.
- Publication Type:Journal Article
- Keywords:
Buyang Huanwu Decoction;
acute myocardial infarction;
autophagy of platelets;
mTOR-autophagy pathway
- MeSH:
Rats;
Animals;
Rats, Sprague-Dawley;
Drugs, Chinese Herbal/therapeutic use*;
Myocardial Infarction/genetics*;
Myocardium/metabolism*;
Aspirin/therapeutic use*;
TOR Serine-Threonine Kinases/metabolism*;
Membrane Proteins/metabolism*;
Mitochondrial Proteins
- From:
China Journal of Chinese Materia Medica
2023;48(15):4156-4163
- CountryChina
- Language:Chinese
-
Abstract:
This study explored the effects of Buyang Huanwu Decoction(BYHWD) on platelet activation and differential gene expression after acute myocardial infarction(AMI). SD rats were randomly divided into a sham-operated group, a model group, a positive drug(aspirin) group, and a BYHWD group. Pre-treatment was conducted for 14 days with a daily oral dose of 1.6 g·kg~(-1) BYHWD and 0.1 g·kg~(-1) aspirin. The AMI model was established using the high ligation of the left anterior descending coronary artery method. The detection indicators included myocardial infarct size, heart function, myocardial tissue pathology, peripheral blood flow perfusion, platelet aggregation rate, platelet membrane glycoprotein CD62p expression, platelet transcriptomics, and differential gene expression. The results showed that compared with the sham-operated group, the model group showed reduced ejection fraction and cardiac output, decreased peripheral blood flow, and increased platelet aggregation rate and CD62p expression, and activated platelets. At the same time, TXB_2 content increased and 6-keto-PGF1α content decreased in serum. Compared with the model group, BYHWD increased ejection fraction and cardiac output, improved blood circulation in the foot and tail regions and cardiomyocytes arrangement, reduced myocardial infarct size and inflammatory infiltration, down-regulated platelet aggregation rate and CD62p expression, reduced serum TXB_2 content, and increased 6-keto-PGF1α content. Platelet transcriptome sequencing results revealed that BYHWD regulated mTOR-autophagy pathway-related genes in platelets. The differential gene expression levels were detected using real-time quantitative PCR. BYHWD up-regulated mTOR, down-regulated autophagy-related FUNDC1 and PINK genes, and up-regulated p62 gene expression. The results demonstrated that BYHWD could regulate platelet activation, improve blood circulation, and protect ischemic myocardium in AMI rats, and its mechanism is related to the regulation of the mTOR-autophagy pathway in platelets.
